期刊文献+

阿奇霉素对哮喘致敏大鼠气道炎症及Th1/Th2失衡的调节作用 被引量:4

Effect of Azithromycin on Ovalbumin-Induced Allergic Airway Inflammation and Regulation of Th1/Th2 Imbalance
下载PDF
导出
摘要 目的:探讨阿奇霉素对哮喘(OVA)致敏大鼠气道炎症及Th1/Th2失衡的调节作用。方法:SD大鼠40只,随机分为生理盐水组、哮喘模型组、地塞米松组以及阿奇霉素组,每组10只。利用卵白蛋白(Ovalbumin,OVA)/Al(OH)3致敏与OVA雾化吸入激发建立大鼠过敏性气道炎症模型,收集肺泡灌洗液(BALF)进行白细胞分类计数。采用ELISA法测定肺泡灌洗液中IL-2、IL-4、TNF-α与ET-1的表达情况。光镜观察肺组织病理结构变化。结果:OVA模型大鼠肺泡灌洗液中的中性粒细胞、淋巴细胞以及嗜酸性粒细胞含量明显增加;HE染色观察肺组织病理结构出现明显的支气管上皮脱落、杯状细胞增生,支气管周围嗜酸性粒细胞明显浸润现象;BALF中IL-2、IL-4、TNF-α与ET-1的表达均明显高于生理盐水对照组(P<0.05)。阿奇霉素则显著降低肺泡灌洗液中中性粒细胞、淋巴细胞以及嗜酸性粒细胞含量;明显改善支气管上皮脱落、杯状细胞增生,支气管周围嗜酸性粒细胞浸润现象;BALF中IL-2、IL-4、TNF-α与ET-1的表达也明显低于OVA模型大鼠(P<0.05)。结论:阿奇霉素通过调节Th1/Th2失衡对过敏性哮喘的气道炎症具有明显的治疗作用。 Objective : To investigate the effect of Azithromycin on ovalbumin - induced allergic airway inflammation and regulation of Thl/Th2 imbalance. Methods :40 male SD rats were randomly divided into Azithromycin group and dexamethasone group and saline group and asthma model group. Ovalbumin (OVA)/Al ( OH )3 sensitization and OVA pulverization inhalation induced allergic airway inflammation model which was assessed by quantifying leukocytes in the airway, expression of multiple inflammatory mediators in the BALF; and there was histological examination in lung. Results: Azithromycin at the dose of 25 mg/kg had anti - inflammation properties in the model of allergic airway inflammation. Compared to treatment with saline, azithromycin attenuated the ovalbumin - dependent airway inflammation, included accumulation of neutrophils, lymphocytes and eosinophils, secretion of ET - 1, IL - 2, IL - 4 and TNF - α, and mucus cell hyperplasia. Conclusion : Azithromycin play an important role in ovalbumin-induced allergic airway inflammation via regulation of Th1/Th2 imbalance.
出处 《现代临床医学》 2012年第3期176-178,共3页 Journal of Modern Clinical Medicine
关键词 阿奇霉素 过敏性 气道炎症 TH1/TH2失衡 Azithromycin asthma inflammation Thl/Th2 imbalance
  • 相关文献

参考文献7

二级参考文献42

  • 1金玲湘,温怀凯,颜雪琴,翁海霞.长期小剂量阿奇霉素治疗慢性阻塞性肺疾病的初步研究[J].中国药物与临床,2004,4(12):916-918. 被引量:10
  • 2中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(草案)[J].中华结核和呼吸杂志,2005,28(11):738-744. 被引量:1456
  • 3Takizawa H, Desaki M, Ohtoshi T, et al. Erythromycin supperlesses interleukin-6 expression by human bronchial epithelial cells:a potential mechanism of its anti-inflammatory action[J]. Biochem Biophys Res Commun, 1995,210( 3 ) : 781 - 786.
  • 4Amsden GW. Anti-inflammatory effects of macrolides-an underappreciated benefit in the treatment of communityacquired respiratory tract infections and chronic inflammatory pulmonary conditions? [J]. J Antimicrob Chemother, 2005, 55(1):10- 21.
  • 5Hatipoglu U, Rubinstein I. Low-dose, long-term macrolide therapy in asthma: an overview[J].Clin Mol Allergy, 2004, 2(1) :4.
  • 6Wales D, Woodhead M. The anti-inflammatory effects of maerolides[J]. Thorax, 1999,54(2) : S58 - S62.
  • 7Sharma S, Jaffe A, Dixon G. Immunomodulatory Effects of MacrolideAntibiotics in Respiratory Disease: Therapeutic Implications for Asthma and Cystic Fibrosis[J]. Paediatr Drugs,2007 9(2) :107 - 118.
  • 8Rubin BK, Henke MO. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease[J]. Chest,2004,125(2) :70S- 78S.
  • 9Kostadima E, Tsiodras S, Alexopoulos El, et al. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma[J]. Eur Respir J ,2004,23(5) :714 - 717.
  • 10Johnston SL, Blasi F, Black PN, et al. The effect of telithromycin in acute exacerbations of asthma[J]. N Engl J Med,2006,354(15):1 589-1 600.

共引文献73

同被引文献48

  • 1薛新东,杜立忠,毛萌,等.儿科学[M].北京:人民卫生出版社,2011:281—287.
  • 2WILLIAMS J D. Non-antimicrobial activities of macrolides[J]. Int J Antimicrob Agents, 2001,18,(Suppl 1)89-91.
  • 3ZHAO Y, YANG J, GAO Y D, et al. Thl7 immunity in pa- tients with allergic asthma[J]. Int Arch Allergy Immunol, 2010,151(4)297-307.
  • 4BULLENS D M, TRUYEN E, COTEUR L, et al. IL-17 mRNA in sputum of asthmatic patients: linking T ceil driven inflammation and granulocytic influx[J]? Respir Res, 2006,7:135.
  • 5SCHNYDER-CANDRIAN S, TOGBE D, COUILLIN I, et al. Interleukin-17 is a negative regulator of established allergic asthma[J].J Exp Med, 2006,203(12) :2715-2725.
  • 6PICHAVANT M, GOYA S, MEYER E H, et al. Ozone ex- posure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17[J]. J Exp Med, 2008,205(2) :385-393.
  • 7OPPMANN B, LESLEY R, BLOM B, et al. Novel p19 pro- tein engages IL-12p40 to form a cytokine, IL-23, with biologi- cal activities similar as well as distinct from IL-12[J]. Immuni- ty, 2000,13(5) :715-725.
  • 8WAKASHIN H, HIROSE K, MAEZAWA Y, et al. 1L-23 and Thl7 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice[J]. Am J Respir Crit Care Med, 2008, 178(10) : 1023-1032.
  • 9VAZQUEZ-TELLO A, SEMLALI A, CHAKIR J, et al. In- duction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines[J]. Clin Exp Allergy, 2010,40(9) :1312-1322.
  • 10MCKINLEY L, ALCORN J F, PETERSON A, et al. Th17 cells mediate steroid-resistant airway inflammation and airway hyperre- sponsiveness in mice[J]. J Immunol, 2008,181(6):4089-4097.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部